A. C. C. Caballero Gonzalez

Immune effector cell-associated neurotoxicity syndrome: A therapeutic approach in the critically ill.

J. Suarez Montero, J. Mancebo Cortés, A. C. C. Caballero Gonzalez, 2022, Medicina intensiva.

Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy

P. Abrisqueta, J. Sancho, A. Sureda, 2022, Blood.

Phase 1 Clinical Trial of Memory-Enriched Academic HSP-CAR30 for the Treatment of Relapsed/Refractory Hodgkin Lymphoma and CD30+ T-Cell Lymphoma: Clinical and Biological Studies

J. Briones, R. Martino, A. Esquirol, 2022, Blood.

Immune effector cell-associated neurotoxicity syndrome: A therapeutic approach in the critically ill.

J. M. Cortés, J.C. Suarez Montero, A.C. Caballero Gonzalez, 2020, Medicina intensiva.